Exceptional Clinical Response to Alpelisib in a Patient with Metastatic Breast Cancer with Hyperbilirubinemia and a PIK3CA Mutation

Journal Title: Journal of Clinical Medical Research - Year 2024, Vol 5, Issue 1

Abstract

In the era of personalized and precision medicine, the importance of next-generation sequencing in metastatic breast cancer has been increasingly recognized. This case highlights one such example in which a patient with heavily pretreated, hormone receptor-positive metastatic breast cancer was discovered to have a PIK3CA mutation and started on a PIK3 inhibitor with an exceptional response. This patient had been facing a visceral crisis with diffuse liver metastasis and hyperbilirubinemia. Alpelisib was able to achieve rapid disease control within a matter of weeks with clinical and objective laboratory improvement. To date, there has been no published data regarding the safety of alpelisib in patients with elevated bilirubin and this case report lends support to safety and efficacy in this situation.

Authors and Affiliations

Elim Kuo, Jacqueline Kropf, Said Baidas, SJ Carlan

Keywords

Related Articles

c-Kit – The Novel Receptor: Physiological Roles, Downstream Signaling and Implications in Cancer

The belief that adult mammalian heart lacks regenerative potential was challenged by the identification of c-kit positive Cardiac Progenitor Cells (CPCs) in the heart. SCIPIO; a phase I clinical trial; has shown that a...

Genodermatoses and Therapeutics on the Horizon: A Review and Table Summary

Over the last decade with the advent of new genetic technologies such as CRISPR and more recently described, seekRNA, we now have the ability to transfer genetic materials through retroviruses or other tools to directly...

Exertional Weakness Seen as An Important Clinical Manifestation in Female Carriers of Duchenne Muscular Dystrophy

Introduction: Duchenne Muscular Dystrophy is an X-linked recessive condition caused by dystrophin mutations. Case Presentation: Three unrelated women who were carrying a pathogenic dystrophin mutation were evaluated w...

OneHealth Applications of Low Level Laser Therapy

Advances in human medicine have long been founded on the initial research conducted with animals. New products and innovative treatment options that are successful in pre-clinical rodent, canine and/or nonhuman primate...

Robotically Assisted Implantology - A Systematic Review from a Young Dental Professional’s Perspective: I Have No Fear, My Dental Robot Is Near!

Objective: There are multiple opportunities to enhance the quality of dental care through robotics. Robotics-assisted dentistry continues to evolve from traditional navigational surgery to more complex systems that prove...

Download PDF file
  • EP ID EP731538
  • DOI http://dx.doi.org/10.46889/JCMR.2024.5107
  • Views 48
  • Downloads 0

How To Cite

Elim Kuo, Jacqueline Kropf, Said Baidas, SJ Carlan (2024). Exceptional Clinical Response to Alpelisib in a Patient with Metastatic Breast Cancer with Hyperbilirubinemia and a PIK3CA Mutation. Journal of Clinical Medical Research, 5(1), -. https://europub.co.uk/articles/-A-731538